Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia

Oxaliplatin-induced peripheral neuropathy (OIPN) is a serious side effect that impairs the quality of life of patients treated with the chemotherapeutic agent, oxaliplatin. The underlying pathophysiology of OIPN remains unclear, and there are no effective therapeutics. This study aimed to investigat...

Full description

Bibliographic Details
Main Authors: Ji Hwan Lee, Jong Hee Choi, Jaihwan Kim, Tai Wan Kim, Ji-Young Kim, Geehoon Chung, Ik-Hyun Cho, Dae Sik Jang, Sun Kwang Kim
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/23/8138
_version_ 1797462663863730176
author Ji Hwan Lee
Jong Hee Choi
Jaihwan Kim
Tai Wan Kim
Ji-Young Kim
Geehoon Chung
Ik-Hyun Cho
Dae Sik Jang
Sun Kwang Kim
author_facet Ji Hwan Lee
Jong Hee Choi
Jaihwan Kim
Tai Wan Kim
Ji-Young Kim
Geehoon Chung
Ik-Hyun Cho
Dae Sik Jang
Sun Kwang Kim
author_sort Ji Hwan Lee
collection DOAJ
description Oxaliplatin-induced peripheral neuropathy (OIPN) is a serious side effect that impairs the quality of life of patients treated with the chemotherapeutic agent, oxaliplatin. The underlying pathophysiology of OIPN remains unclear, and there are no effective therapeutics. This study aimed to investigate the causal relationship between spinal microglial activation and OIPN and explore the analgesic effects of syringaresinol, a phytochemical from the bark of Cinnamomum cassia, on OIPN symptoms. The causality between microglial activation and OIPN was investigated by assessing cold and mechanical allodynia in mice after intrathecal injection of the serum supernatant from a BV-2 microglial cell line treated with oxaliplatin. The microglial inflammatory response was measured based on inducible nitric oxide synthase (iNOS), phosphorylated extracellular signal-regulated kinase (p-ERK), and phosphorylated nuclear factor-kappa B (p-NF-κB) expression in the spinal dorsal horn. The effects of syringaresinol were tested using behavioral and immunohistochemical assays. We found that oxaliplatin treatment activated the microglia to increase inflammatory responses, leading to the induction of pain. Syringaresinol treatment significantly ameliorated oxaliplatin-induced pain and suppressed microglial expression of inflammatory signaling molecules. Thus, we concluded that the analgesic effects of syringaresinol on OIPN were achieved via the modulation of spinal microglial inflammatory responses.
first_indexed 2024-03-09T17:40:50Z
format Article
id doaj.art-939b847a0e304d338eac3b4756d0f151
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T17:40:50Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-939b847a0e304d338eac3b4756d0f1512023-11-24T11:37:14ZengMDPI AGMolecules1420-30492022-11-012723813810.3390/molecules27238138Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal MicrogliaJi Hwan Lee0Jong Hee Choi1Jaihwan Kim2Tai Wan Kim3Ji-Young Kim4Geehoon Chung5Ik-Hyun Cho6Dae Sik Jang7Sun Kwang Kim8Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Convergence Medical Science, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of East-West Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Convergence Medical Science, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of KoreaDepartment of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of KoreaOxaliplatin-induced peripheral neuropathy (OIPN) is a serious side effect that impairs the quality of life of patients treated with the chemotherapeutic agent, oxaliplatin. The underlying pathophysiology of OIPN remains unclear, and there are no effective therapeutics. This study aimed to investigate the causal relationship between spinal microglial activation and OIPN and explore the analgesic effects of syringaresinol, a phytochemical from the bark of Cinnamomum cassia, on OIPN symptoms. The causality between microglial activation and OIPN was investigated by assessing cold and mechanical allodynia in mice after intrathecal injection of the serum supernatant from a BV-2 microglial cell line treated with oxaliplatin. The microglial inflammatory response was measured based on inducible nitric oxide synthase (iNOS), phosphorylated extracellular signal-regulated kinase (p-ERK), and phosphorylated nuclear factor-kappa B (p-NF-κB) expression in the spinal dorsal horn. The effects of syringaresinol were tested using behavioral and immunohistochemical assays. We found that oxaliplatin treatment activated the microglia to increase inflammatory responses, leading to the induction of pain. Syringaresinol treatment significantly ameliorated oxaliplatin-induced pain and suppressed microglial expression of inflammatory signaling molecules. Thus, we concluded that the analgesic effects of syringaresinol on OIPN were achieved via the modulation of spinal microglial inflammatory responses.https://www.mdpi.com/1420-3049/27/23/8138inflammationmicroglianeuropathic painoxaliplatinphytochemicalsyrinagresinol
spellingShingle Ji Hwan Lee
Jong Hee Choi
Jaihwan Kim
Tai Wan Kim
Ji-Young Kim
Geehoon Chung
Ik-Hyun Cho
Dae Sik Jang
Sun Kwang Kim
Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia
Molecules
inflammation
microglia
neuropathic pain
oxaliplatin
phytochemical
syrinagresinol
title Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia
title_full Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia
title_fullStr Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia
title_full_unstemmed Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia
title_short Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia
title_sort syringaresinol alleviates oxaliplatin induced neuropathic pain symptoms by inhibiting the inflammatory responses of spinal microglia
topic inflammation
microglia
neuropathic pain
oxaliplatin
phytochemical
syrinagresinol
url https://www.mdpi.com/1420-3049/27/23/8138
work_keys_str_mv AT jihwanlee syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia
AT jongheechoi syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia
AT jaihwankim syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia
AT taiwankim syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia
AT jiyoungkim syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia
AT geehoonchung syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia
AT ikhyuncho syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia
AT daesikjang syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia
AT sunkwangkim syringaresinolalleviatesoxaliplatininducedneuropathicpainsymptomsbyinhibitingtheinflammatoryresponsesofspinalmicroglia